$MRK Climbs Toward $120 Resistance After Positive Phase III Results 🔥
$Merck(MRK)$ $Merck & Co., Inc.(MRK) Jumps +2.55%: Key Drug Trial Success Fuels Rally, $120 Breakout in Sight 📈 Latest Close Data: 🕐 MRK closed at $115.88 on May 22, up +2.55% (+$2.88). The stock is now ~$9.26 (7.4%) below its 52-week high of $125.14. Core Market Drivers: 💊 The surge was primarily driven by positive Phase III clinical trial results for its TROP2 ADC therapy in endometrial cancer, announced after-hours on May 21. This promising data reinforces its oncology pipeline strength, following a strong Q1 earnings report that exceeded expectations and led to a raised full-year guidance. Technical Analysis: 📊 The rally is supported by rising volume (7.4M shares) and bullish momentum signals. The daily RSI(6) has climbed to 67.32, approach
$JMIA Rallies +2.75% as Africa E-Commerce Tests $7 Breakout 🚀
$Jumia Technologies AG(JMIA)$ $Jumia Technologies AG(JMIA) Rallied +2.75%: African E-Commerce Giant Tests Key Resistance, $7.10 Breakout in Sight 📈 Latest Close Data: 🕒 Jumia closed at $7.10 on May 22, 2026, up +2.75% (+$0.19). The stock is trading 51.8% below its 52-week high of $14.72. Core Market Drivers: 🌍 The stock's recent volatility is driven by mixed signals in emerging markets and ongoing investor scrutiny of its path to profitability. Recent capital flow data shows persistent net outflows over the past week, indicating lingering investor caution. Technical Analysis: 📊 Volume was 2.46M shares with a Volume Ratio of 1.17, suggesting slightly above-average activity. The 6-day RSI is at 46.21, moving out of oversold territory but still below
Can ARM Experience Potential AI Slowdown After Benefitting From AI Compute Expansion?
$ARM Holdings(ARM)$’s recent surge past $260 to fresh all-time highs (spurred by their blowout Q4 FY2026 earnings) is a result of a massive shift in how the market views the company. They are no longer viewed just as a mobile chip licensor, but as a central architect of the AI infrastructure boom. I am holding ARM for long term, having DCA a couple of times when ARM is experiencing price corrections. So I am exploring how we can use option to continue to play into ARM strength (royalty benefit). The Catalysts: Royalty Beneficiary vs. Joining the Race? The short answer is: It is both, but the mechanics are shifting. The Royalty & Architecture Play (The Immediate Driver) ARM is capturing a massive slice of the AI compute expansion through its Arm
$D-Wave Quantum Inc.(QBTS)$ I have always believed that quantum computing represents the next massive leap forward for the tech sector, though because the industry is still in its absolute infancy, I purposely keep my position sizes very small. We saw how volatile this space can be around September and October of last year when government interest sparked a massive parabolic move, sending my primary ticker QBTS up over 180% within a month before completely sizzling out. Taking a disciplined, small-sized approach keeps the portfolio safe from those wild, speculative swings while still leaving the door open for the real shifts. That real shift might be starting to take shape with the Trump administration’s fresh announcement of a $2 billion fu
$Advanced Micro Devices(AMD)$ what a big rise again! Keep flying all the time and going reach another All Tome High! $Tesla Motors(TSLA)$ I'm waiting this another perfect share fly to the moon too! Let's fly!
$NVIDIA(NVDA)$ It's always down a bit then fly further high after its report out! Just wait for profit! $Advanced Micro Devices(AMD)$ this one no report also fly to the moon always! Meet you guys at the moon later!
$AXTI 20260529 101.0 PUT$ I’ve observed AXTI fluctuating within the 105 to 125 range. When the price approaches 105, I take the opportunity to sell put options. Using this approach, I’ve successfully locked in profits on several trades.🫰🏻🤞🏻
$SE Reclaims Momentum After Q1 Beat, Bulls Eye $95 Resistance
$Sea Ltd(SE)$ $Sea Ltd (SE) Rallies +2.78%: Tech Giant Reclaims $89 Pivot, Eyes $95 Resistance 📈 Latest Close Data Closed at $88.96 on May 22, up +2.78% (+$2.41). It remains -55.4% below its 52-week high of $199.30. 🎯 Core Market Drivers The stock is rebounding from a post-earnings pullback. The primary driver remains the stellar Q1 earnings report (May 12), where revenue surged +46.6% YoY to $7.1B, significantly beating estimates. AI-driven growth in Shopee and a strong performance from Garena are fueling long-term optimism. 📊 Technical Analysis Volume was 3.12M shares (Volume Ratio: 0.76), indicating average participation. The MACD (DIF: 0.41, DEA: 0.39, MACD: 0.035) shows a slight bullish crossover, hinting at potential momentum building. The RSI
$HON Hits Overbought Territory as Bulls Push Toward $225
$Honeywell(HON)$ $Honeywell(HON) Surged +2.95%: Defense Contract Ignites Breakout, Eyes on $244.5 Target Latest Close Data 📈 Closed at $223.8 on May 22, up +2.95% (+$6.41). The stock is now ~9.8% away from its 52-week high of $248.18. Core Market Drivers 🚀 Major Defense Win: Momentum fueled by securing a $248.9M US Army engine maintenance contract, boosting Aerospace segment outlook. Spin-Off Progress: Positive sentiment continues around the planned Aerospace division spin-off, expected in Q3, seen as a value-unlocking catalyst. Technical Analysis 📊 Volume: Healthy volume of 4.73M shares supports the breakout move. RSI (6): Jumped to 72.22, indicating strong short-term momentum but entering overbought territory. MACD: Histogram turned positive at 2
$BMNR 20260522 20.0 CALL$ BMMR: selling calls for those assigned at $20 last week. Price continue to weaken so I'll hold on to them for a while and ride this out.